Source link : https://newshealth.biz/health-news/fda-approves-niraparib-abiraterone-acetate-combo-for-cspc/
The treatment combination was previously approved in BRCA2m-positive patients with metastatic castrate-resistant prostate cancer. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-approves-niraparib-abiraterone-acetate-combo-cspc-2025a1000z65?src=rss Author : Publish date : 2025-12-15 18:14:00 Copyright for syndicated content belongs to the linked Source.
The post FDA Approves Niraparib-abiraterone Acetate Combo for CSPC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-15 18:14:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8